Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell × Immunotherapy × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9 Melanoma 4 Esophageal Neoplasms 4 Neoplasm Metastasis 3 Lung Neoplasms 3 Rectal Neoplasms 2 Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Breast Neoplasms, Male 2 Breast Neoplasms 2 Turcot syndrome 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Small Cell Lung Cancer Extensive Stage 1 Sarcoma 1 Radiation Injuries 1 Pathologic Complete Response 1 Pancreatic Cancer Liver Metastases 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasm, Residual 1 Muscle-invasive Bladder Cancer 1 Liver Neoplasms 1 Liver Diseases 1 Limited Stage Small Cell Lung Cancer 1 Kidney Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1

Interventions

Cyclophosphamide 16 Rituximab 13 fludarabine 10 pirtobrutinib 7 Specimen Handling 7 Magnetic Resonance Spectroscopy 7 glofitamab 5 Doxorubicin 5 venetoclax 4 fludarabine phosphate 4 Vincristine 4 Prednisone 4 Leukapheresis 4 Biopsy 4 zanubrutinib 3 polatuzumab vedotin 3 pembrolizumab 3 obinutuzumab 3 Lenalidomide 3 Etoposide 3 Dexamethasone 3 Bendamustine Hydrochloride 3 tazemetostat 2 tafasitamab 2 axicabtagene ciloleucel 2 acalabrutinib 2 Gemcitabine 2 Cytarabine 2 Cisplatin 2 Calcium Dobesilate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡